COMPARISON OF SULFITE AND THROMBIN METHODS FOR MEASURING FIBRINOGEN CONCENTRATION OF PLASMA FROM PATIENTS UNDERGOING THROMBOLYTIC THERAPY

被引：12

作者：

LANE, DA

RAMPLING, MW

KAKKAR, VV

机构：

[1] KINGS COLL HOSP,SCH MED,DEPT SURG,THROMBOSIS RES UNIT,LONDON SE5 8RX,ENGLAND

[2] ST MARYS HOSP,SCH MED,DEPT BIOPHYS,LONDON W2 1PG,ENGLAND

来源：

CLINICA CHIMICA ACTA | 1976年 / 71卷 / 01期

关键词：

D O I：

10.1016/0009-8981(76)90269-2

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：15 / 19

页数：5

共 13 条

[1]

BLOMBACK B, 1956, ARK KEMI, V10, P415

[2] SOLUBLE HIGH-MOLECULAR-WEIGHT E-FRAGMENTS IN PLASMIN-INDUCED DEGRADATION PRODUCTS OF CROSS-LINKED HUMAN FIBRIN [J].

GAFFNEY, PJ ;

LANE, DA ;

BRASHER, M .

CLINICAL SCIENCE AND MOLECULAR MEDICINE, 1975, 49 (02) :149-156

[3]

GOODWIN JF, 1965, CLIN CHEM, V11, P63

[4] *METHODE PERMETTANT LETUDE CONJUGUEE DES PROPRIETES ELECTROPHORETIQUES ET IMMUNOCHIMIQUES DUN MELANGE DE PROTEINES - APPLICATION AU SERUM SANGUIN [J].

GRABAR, P ;

WILLIAMS, CA .

BIOCHIMICA ET BIOPHYSICA ACTA, 1953, 10 (01) :193-194

[5] TANNED RED-CELL HEMAGGLUTINATION-INHIBITION IMMUNOASSAY OF FIBRINOGEN-FIBRIN DEGRADATION PRODUCTS METHODOLOGICAL AND STATISTICAL ASPECTS [J].

HAHN, L .

THROMBOSIS RESEARCH, 1974, 4 (03) :417-436

[6]

KAKKAR VV, 1975, LANCET, V2, P674

[7]

LANE DA, IN PRESS

[8]

MARDER VJ, 1969, J BIOL CHEM, V244, P2120

[9] DATA FOR DEFINING FIBRINOGEN AND ITS PLASMIC DEGRADATION PRODUCTS [J].

MARDER, VJ ;

BUDZYNSKI, AZ .

THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1975, 33 (02) :199-207

[10]

MERSKEY C, 1966, BLOOD-J HEMATOL, V28, P1

← 1 2 →